{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06174935",
            "orgStudyIdInfo": {
                "id": "1362664"
            },
            "organization": {
                "fullName": "Prism Vision Group",
                "class": "OTHER"
            },
            "briefTitle": "Low Dose Atropine for Symptomatic Vitreous Floaters",
            "officialTitle": "Low Dose Atropine For Symptomatic Vitreous Floaters",
            "therapeuticArea": [
                "Other"
            ],
            "study": "low-dose-atropine-for-symptomatic-vitreous-floaters"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-12",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-01-01",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-06-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-06-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-11-28",
            "studyFirstSubmitQcDate": "2023-12-08",
            "studyFirstPostDateStruct": {
                "date": "2023-12-18",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-12-08",
            "lastUpdatePostDateStruct": {
                "date": "2023-12-18",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Jeanette Du",
                "investigatorTitle": "Physician",
                "investigatorAffiliation": "Prism Vision Group"
            },
            "leadSponsor": {
                "name": "Jeanette Du",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The objective of this study is to identify a potential pharmacologic option by assessing whether 0.01% atropine may be effective for treating bothersome floaters as measured by scores on a modified NEI VFQ-25."
        },
        "conditionsModule": {
            "conditions": [
                "Vitreous Floaters"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 200,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Atropine 0.01%",
                    "type": "EXPERIMENTAL",
                    "description": "Patients will apply 1 drop daily of atropine 0.01%",
                    "interventionNames": [
                        "Drug: 0.01% atropine ophthalmic drop"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "0.01% atropine ophthalmic drop",
                    "description": "0.01% atropine ophthalmic drop will be applied daily to the affected eye",
                    "armGroupLabels": [
                        "Atropine 0.01%"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Symptom improvement assessed by questionnaire",
                    "description": "NEI VFQ-25 = National Eye Institute Visual Function Questionnaire",
                    "timeFrame": "Up to 2 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult patients within Prism Vision Group with ICD diagnosis of acute posterior vitreous detachment and none of the ocular comorbidities listed as exclusion criteria will be screened as potential study participants.\n\nExclusion Criteria:\n\n* Patients with vitreous hemorrhage, other significant media opacity or vitreoretinal pathology, or history of pars plana vitrectomy will be excluded.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "19 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jeanette Du, MD",
                    "role": "CONTACT",
                    "phone": "844-749-3627",
                    "email": "JDu@rgw.com"
                }
            ],
            "locations": [
                {
                    "facility": "Retina Group of Washington",
                    "city": "Reston",
                    "state": "Virginia",
                    "zip": "20190",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jeanette Du, MD",
                            "role": "CONTACT",
                            "phone": "844-749-3627",
                            "email": "jdu@rgw.com"
                        },
                        {
                            "name": "Jeanette Du, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Mohsin Ali, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.96872,
                        "lon": -77.3411
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "asFound": "Vitreous Floaters",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001285",
                    "term": "Atropine"
                },
                {
                    "id": "D000009883",
                    "term": "Ophthalmic Solutions"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000759",
                    "term": "Adjuvants, Anesthesia"
                },
                {
                    "id": "D000000889",
                    "term": "Anti-Arrhythmia Agents"
                },
                {
                    "id": "D000001993",
                    "term": "Bronchodilator Agents"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018927",
                    "term": "Anti-Asthmatic Agents"
                },
                {
                    "id": "D000019141",
                    "term": "Respiratory System Agents"
                },
                {
                    "id": "D000009184",
                    "term": "Mydriatics"
                },
                {
                    "id": "D000010276",
                    "term": "Parasympatholytics"
                },
                {
                    "id": "D000018727",
                    "term": "Muscarinic Antagonists"
                },
                {
                    "id": "D000018680",
                    "term": "Cholinergic Antagonists"
                },
                {
                    "id": "D000018678",
                    "term": "Cholinergic Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000019999",
                    "term": "Pharmaceutical Solutions"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12814",
                    "name": "Ophthalmic Solutions",
                    "asFound": "Current smokers",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4590",
                    "name": "Atropine",
                    "asFound": "Days per",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M4107",
                    "name": "Anesthetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M4089",
                    "name": "Adjuvants, Anesthesia",
                    "relevance": "LOW"
                },
                {
                    "id": "M4213",
                    "name": "Anti-Arrhythmia Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M5269",
                    "name": "Bronchodilator Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20963",
                    "name": "Anti-Asthmatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M21137",
                    "name": "Respiratory System Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M12139",
                    "name": "Mydriatics",
                    "relevance": "LOW"
                },
                {
                    "id": "M13189",
                    "name": "Parasympatholytics",
                    "relevance": "LOW"
                },
                {
                    "id": "M20801",
                    "name": "Muscarinic Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20758",
                    "name": "Cholinergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20760",
                    "name": "Cholinergic Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AnArAg",
                    "name": "Anti-Arrhythmia Agents"
                },
                {
                    "abbrev": "AdjAn",
                    "name": "Adjuvants, Anesthesia"
                },
                {
                    "abbrev": "Resp",
                    "name": "Respiratory System Agents"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                }
            ]
        }
    },
    "hasResults": false
}